![]() |
|
|
Vol. 293, Issue 3, 896-902, June 2000
Eppley Institute (W.X., J.A.S., P.J.W., A.R., S.H.H., O.L.), Department of Biochemistry and Molecular Biology (W.X., A.R., O.L.), and Department of Pathology and Microbiology (J.A.S., A.R., R.D.M., S.H.H.), University of Nebraska Medical Center, Omaha, Nebraska; Departement de Physiologie Animale, Institut National de la Recherche Agronomique, Montpellier, France (A.C.); and Department of Pharmacology, University of California at San Diego, La Jolla, California (P.T.)
| |
Abstract |
|---|
|
|
|---|
Acetylcholinesterase (AChE; EC 3.1.1.7) is the primary terminator of
nerve impulse transmission at cholinergic synapses and is believed to
play an important role in neural development. Targeted deletion of four
exons of the ACHE gene reduced AChE activity by half in
heterozygous mutant mice and totally eliminated AChE activity in
nullizygous animals. Butyrylcholinesterase (EC 3.1.1.8) activity was
normal in AChE
/
mice. Although nullizygous mice were born alive
and lived up to 21 days, physical development was delayed. The
neuromuscular junction of 12-day-old nullizygous animals appeared
normal in structure. Nullizygous mice were highly sensitive to the
toxic effects of the organophosphate diisopropylfluorophosphate and to
the butyrylcholinesterase-specific inhibitor bambuterol. These findings
indicate that butyrylcholinesterase and possibly other enzymes are
capable of compensating for some functions of AChE and that the
inhibition of targets other than AChE by organophosphorus agents
results in death.
| |
Introduction |
|---|
|
|
|---|
Acetylcholine
is the primary neurotransmitter of the cholinergic system, and its
activity is regulated through hydrolysis in nerve synapses by
acetylcholinesterase (AChE). The termination of nerve impulse
transmission is accomplished through the degradation of acetylcholine
into choline and acetic acid by AChE. Although the importance of AChE
in the function of the nervous system has been recognized for more than
80 years, its role in development remains enigmatic (Robertson, 1987
;
Layer, 1996
; Andres et al., 1997
; Bigbee et al., 1999
; Brimijoin and
Koenigsberger, 1999
; Lassiter et al., 1998
). AChE activity is found in
brain regions that are devoid of cholinergic neurons, acetylcholine,
and acetylcholine receptors (Greenfield, 1984
). AChE is transiently
expressed during discrete periods of neural development of the
thalamocortical pathways, and transient AChE activity correlates with
the specific growth of thalamic axons into the cortex and
synaptogenesis with cortical neurons (Robertson and Yu, 1993
). In
addition, significant sequence similarity exists between AChE and cell
adhesion proteins that function in morphogenic phenomena. These
observations have led to the hypothesis that AChE may play key roles in
neural development. Robertson and Yu (1993)
proposed that AChE may be
bound to a proteolytic enzyme that aids the growing axon in maneuvering
through cortical neuropil to reach its target.
The many important functions attributed to the cholinergic system
suggest that sustained life is not possible in the absence of AChE.
Deletion of AChE activity in Drosophila through mutagenesis resulted in embryonic lethality (Greenspan et al., 1980
). Chemicals with anticholinesterase activity such as organophosphorus and carbamate
pesticides are lethal to humans and animals after acute exposure
(Doctor et al., 1991
; Taylor and Radic, 1994
; Cowan et al., 1996
;
Massoulié et al., 1996
; Taylor, 1996
; Mileson et al., 1998
).
Inhalation of the chemical warfare agent Sarin by 5000 people in the
Tokyo subway resulted in acute respiratory failure and the death of 12 (Nagao et al., 1997
). The inhibition of AChE by organophosphorus
poisons produces a massive outpouring of secretions, neuromuscular
block, and central depression of respiration (Namba et al., 1971
), yet
chronic exposure to organophosphates, such as metrifonate for the
treatment of Alzheimer's disease, results in accommodation and is not
lethal (Cutler et al., 1998
).
Mice lacking expression of AChE were generated to investigate the contribution of AChE to development and to explore the potential compensatory role of butyrylcholinesterase (BChE; EC 3.1.1.8). AChE and BChE arise from distinct genes and have about 50% sequence identity. Both enzymes hydrolyze acetylcholine. Contrary to expectation, mice without AChE activity survived to birth and for up to 3 weeks after birth. Therefore, the question was asked whether mice without AChE are sensitive to the organophosphate diisopropylfluorophosphate (DFP).
| |
Experimental Procedures |
|---|
|
|
|---|
Generation of AChE
/
Mice.
A lambda FIX II clone
containing the complete mouse ACHE gene was isolated from a
mouse strain 129SVJ genomic library (Stratagene, La Jolla, CA). The
targeting vector (Fig. 1) for disrupting
the ACHE gene was introduced into R1 embryonic stem cells by
standard methods (Wurst and Joyner, 1993
; Wilder et al., 1997
). Of 200 embryonic stem cell colonies screened by Southern blotting, four contained the desired disrupted allele. Genomic DNA digested with XbaI, NheI, XhoI, or BamHI
and hybridized with the probe indicated in Fig. 1 or with a probe for
the neo gene confirmed that the null allele was present in
these four colonies and that additional copies of the targeting vector
were not randomly integrated into their genomes (data not shown).
Eleven chimeric mice were generated, and two of these transmitted the
ACHE mutant allele in their germline (Xie et al., 1999
). The
phenotype of the two lines was indistinguishable. Chimeric mice were
mated to strain 129sv mice (Taconic 129S6/SvEvTac) to maintain the
ACHE knockout animal in a 129sv background. Mice were fed
Teklad LM-485 mouse/rat irradiated diet (catalog number 7912)
containing 5% fat and 19% protein (Harlan, Madison, WI). Experimental
protocols adhered to the guidelines of the U.S. National Institutes of
Health for the care and use of laboratory animals.
|
Measurement of AChE and BChE Activity.
Tissues from 10- to
12 day-old mice were extracted with 50 mM potassium phosphate, pH 7.4, containing 0.5% Tween 20 and assayed for activity with 1 mM
acetylthiocholine. Tissues were extracted with buffer containing 0.5%
Tween 20 rather than the commonly used Triton X-100 (Massoulié
and Toutant, 1988
; Feng et al., 1999
) because Triton X-100 inhibits 90 to 95% of mouse BChE activity. Heart and skeletal muscle (quadriceps)
pellets from the first extraction were re-extracted with buffer
containing 1 M NaCl to extract the collagen-tailed forms of AChE and
BChE. The activity remaining after AChE was inhibited with 0.01 mM
1,5-bis(4-allyldimethylammonium phenyl)-pentan-3-one was BChE. AChE
activity in intestine was calculated after inhibition of BChE with 0.1 mM tetraisopropylpyrophosphoramide (iso-OMPA).
, and
/
animals was calculated by ANOVA single-factor analysis
using the Excel program in Microsoft Office 98.
Gel Electrophoresis.
Nondenaturing gradient gels of 4 to
30% polyacrylamide and 0.75-mm thick were made in a Hoefer apparatus.
Then, 3 µl of serum was loaded per lane from two wild-type, two AChE
+/
, and three AChE
/
mice. The control samples, human serum and
fetal bovine serum, also were loaded at 3 µl/lane. The upper buffer
contained 600 ml of 0.021 M Trizma base, 0.023 M glycine with
unadjusted pH 9.0; the lower buffer contained 4.5 L of 0.06 M Tris-HCl,
pH 8.1. Electrophoresis was at 4°C for 40 h at a constant
voltage of 100 V. The staining buffer (Karnovsky and Roots, 1964
)
produced a brown precipitate in locations of cholinesterase activity.
The staining buffer contained 1.7 mM acetylthiocholine iodide when it
was desired that all cholinesterase bands be seen but contained 2 mM
butyrylthiocholine iodide when only BChE activity was visualized. To
specifically visualize bands of AChE activity, the gel was incubated
for 30 min with 0.01 mM iso-OMPA, an inhibitor of BChE, before the
addition of acetylthiocholine iodide.
Toxicity Studies.
The 12-day-old mice were injected i.p.
with diisopropylfluorophosphate (DFP) dissolved in PBS. The DFP
solution was prepared just before use because this organophosphate is
unstable in aqueous buffer. The DFP dose of 2.5 mg/kg was chosen after
it was determined that 12-day-old wild-type mice survived this dose but
that a slightly higher dose was lethal to a few wild-type animals.
Bambuterol (Astra Draco AB, Lund, Sweden), a carbamate prodrug of the
antiasthma drug terbutaline (Tunek and Svensson, 1988
), was dissolved
in PBS and injected i.p. Bambuterol is a specific inhibitor of BChE.
Histology.
The 12-day-old animals were perfused with 4%
buffered formalin before tissues were removed. Brains were stored in
10% buffered formalin for 24 h at 4°C and then in 0.1 M PBS
containing 20% sucrose for 2 to 3 days. To facilitate sectioning, each
specimen was embedded in Tissue-Tek OCT Compound (Sakura Finetek USA,
Inc., Torrance, CA) and flash frozen in 2-methylbutane submerged in a
dry ice/ethanol bath. The blocks were stored at
80°C until sectioning. Frozen brains were cut on a cryostat into 20-µm sections. Sections were mounted onto Fisherfinest Premium Superfrost microscope slides (Fisher Scientific), which are electrically charged. Slides were
air-dried and then stored at
80°C until they were stained for AChE
activity by the method of Karnovsky and Roots (1964)
and counterstained
with hematoxylin. The details of the AChE staining procedure are as
follows. The staining buffer was freshly prepared just before use by
mixing 30 ml of 0.2 M maleate (pH adjusted to 6.0 with 1 M NaOH), 2.5 ml of 0.1 M sodium citrate, 5.0 ml of 0.030 M cupric sulfate, 5.0 ml of
0.005 M potassium ferricyanide, and water to a total of 50 ml. The
staining buffer was filtered through a 0.22-µm filter to remove
particulates. When the buffer was not filtered, the slides had dark
spots. Four slides were incubated in 29 ml of the filtered staining
buffer containing 0.1 mM iso-OMPA (0.145 ml of 20 mM iso-OMPA in
water). The purpose of incubating in iso-OMPA was to specifically
inhibit BChE. After 20 min of incubation with gentle shaking, 0.29 ml
of 0.2 M acetylthiocholine was added. The incubation with 2 mM
acetylthiocholine was for 2.5 h at 25°C. At the end of the
incubation period, the slides were washed with water 10 times and then
fixed in 4% formalin in PBS for 15 min at room temperature. The slides
were dipped in hematoxylin for 40 s and then five times each in
80, 95, 100% ethanol, and xylene and covered with a drop of glue and a coverslip.
Electron Microscopy. The 12-day-old mice were perfused trans-cardially with physiological saline containing 2.5% glutaraldehyde and 2% paraformaldehyde in phosphate buffer. The quadriceps muscle was dissected and fixed overnight in the same fixative. The midportion of the muscle was isolated, postfixed in buffered 1% osmium tetroxide for 1 h, dehydrated, and embedded in Araldite. Thin sections were stained with uranyl acetate and lead citrate and viewed under the electron microscope.
| |
Results |
|---|
|
|
|---|
A strategy for disrupting expression of AChE using homologous recombination was achieved through the deletion of 5 kb of the mouse ACHE gene (Fig. 1). Deletion of exons 2 through 5 removed 93% of the 583 amino acids comprising AChE. It was expected that ACHE mutant animals would have gross abnormalities or show a maturation arrest in utero at a time when AChE activity was essential for continued development. Although ACHE mutant Drosophila were not viable, the possibility existed that nullizygous ACHE mice would be viable because BChE is not present in Drosophila.
To demonstrate that the recombination event had generated the
anticipated ACHE null allele, genomic DNA from 12-day-old
mice was analyzed by Southern blotting (Fig.
2A) and polymerase chain reaction (Fig.
2B). The results supported the conclusion that the tested 12-day-old
mice had no wild-type ACHE allele but had two null
ACHE alleles.
|
AChE enzyme activity was analyzed in serum from blood of wild-type,
heterozygous, and nullizygous animals using nondenaturing polyacrylamide gels stained for total cholinesterase activity (Fig.
3A) and specifically for AChE activity
(Fig. 3B). Control 12-day-old wild-type mice demonstrated at least nine
bands of cholinesterase activity: six bands were identified as BChE and three were identified as AChE by selective inhibition of BChE with 0.01 mM iso-OMPA (Fig. 3B), as well as by selective inhibition of AChE with
0.03 mM 1,5-bis(4-allyldimethylammoniumphenyl)-pentan-3-one (not shown)
and by selective staining for BChE activity with butyrylthiocholine (not shown). The bands of AChE activity correspond with monomeric, dimeric, and tetrameric forms. The three AChE bands were less intense
in AChE +/
mice and were missing in sera from nullizygous AChE mice.
|
Tissue levels of AChE were evaluated using a spectrophotometric assay
with acetylthiocholine and a specific AChE inhibitor to estimate the
proportion of AChE and BChE activity (Table
1). Cholinergic neurons innervate the
brain, heart, eye, glands, trachea, spleen, stomach, small bowel,
colon, kidney, urinary bladder, external genitalia, and skeletal muscle
(Lefkowitz et al., 1996
), and these tissues all contain AChE. In
wild-type mice, the highest AChE activity was in brain, followed by
serum and intestine. AChE +/
mice had less AChE activity than
wild-type mice in all tissues tested. AChE
/
mice had no detectable
AChE activity in brain, serum, intestine, heart, lung, muscle, and
liver. AChE expression in the nullizygote was further explored by
staining sections of mouse brains for AChE activity. Wild-type and AChE
+/
mouse brains showed intense AChE activity in the caudate and
putamen, whereas AChE
/
brain had no AChE activity (Fig.
4).
|
|
Phenotype.
Observations of movement, behavior, and morphologic
features were initiated to identify possible focal defects in activity or function. The AChE
/
mice were indistinguishable from their littermates at birth through visual inspection. However, weight gain
and growth were retarded, and at 7 days, a clear difference was
noticeable between nullizygous animals and normal littermates (Fig.
5B). Newborn litters were weighed daily
beginning on day 2 after birth, and results were charted. The weights
of AChE
/
mice lagged behind those of wild-type littermates at all
time points and began to fall 1 to 2 days before death. Nullizygous animals were observed to nurse, and their stomachs contained milk curds
at the time of death. However, they appeared emaciated and dehydrated.
|
|
Histology.
The heart, lungs, thymus, liver, spleen, adrenal
glands, kidneys, pancreas, small and large intestines, stomach, and
reproductive organs from AChE
/
animals were examined and showed no
external abnormalities. The cerebral hemispheres of the brain were
translucent in 12-day-old AChE
/
mice but were opaque in normal
littermates. The cerebellum and brain stem showed no external
abnormalities. Light microscopic examination of the small and large
intestines from AChE
/
animals showed no fibrosis or hypertrophy of
the muscularis. Intermyenteric nerves were present, although no AChE activity was apparent by staining. The normal architecture of the
adrenal was maintained. The lungs showed normal expansion without
inflammatory infiltrate. The liver architecture was intact. Normal
striations were apparent in the heart myocytes. No abnormalities were
present in the stomach, spleen, pancreas, kidneys, thymus, or bladder.
No histologic abnormalities were seen in any of the organs from
heterozygous animals.
/
mice
were examined. The Giemsa-stained slides showed normal morphology and
normal numbers of red blood cells, lymphocytes, neutrophils, platelets,
eosinophils, and basophils. No abnormalities in hematopoiesis were found.
Neuromuscular Junction.
Electron microscopy showed that the
neuromuscular junction of AChE nullizygous animals was well formed
(Fig. 7) and normal in size. Excessive
encasement of the normal sized nerve termini by Schwann cell processes
was not seen. The nerve termini contained synaptic vesicles and
mitochondria. A few termini contained membranous material. There was no
evidence of degeneration of the junctional folds.
|
Survival without AChE.
Mating studies of heterozygous animals
were performed to determine whether nullizygous animals were born at
the expected frequency of 25%. After 320 live births, it was
determined that AChE
/
mice were born at a frequency of 20% (Table
2), suggesting that about one-fourth of
the AChE
/
fetuses died in utero and were resorbed. The large
proportion of live births indicated that AChE was not essential during
embryogenesis and fetal development or that compensatory mechanisms
existed. Two possibilities were considered, including that maternal
AChE may have crossed the placenta and supported survival of the
fetuses in utero and that BChE replaced AChE in developmental
activities. No AChE activity was found in the sera of fetuses collected
at day 16.5 post coitus, suggesting there was no maternal transfer of
AChE.
|
/
tissues was similar to that in
wild-type and AChE +/
tissues. These assays provided no direct
evidence that BChE substituted for AChE in animals devoid of AChE
activity, although they did not rule out the possibility that the
normal levels of BChE present in tissues allowed the nullizygotes to
progress through natal development and survive after birth.
The majority of AChE nullizygous mice remained alive at day 12 but died
between postnatal days 13 to 21, as demonstrated in the survival curve
(Fig. 5A). None survived longer than 21 days. In contrast, no increased
mortality rate was seen in heterozygous animals.
Toxicity.
It is generally agreed that the acute effects of
poisoning by organophosphates are due to inhibition of AChE activity
(Taylor, 1996
; Pope, 1999
). Because AChE
/
mice have no AChE enzyme
activity, it was of interest to know whether nullizygotes would be
resistant to the toxic effects of organophosphates. When the
nonselective serine esterase and serine protease inhibitor,
diisopropylfluorophosphate, was injected i.p. at a dose of 2.5 mg/kg,
the nullizygous mice immediately collapsed and heartbeats ceased within
3 min. The wild-type 12-day-old littermates survived this dose (Table
3). Heterozygous animals had an
intermediate sensitivity; half of the AChE +/
animals survived this
dose. This result demonstrated that AChE is not the only target of
organophosphorus poisons and that inhibition of other enzymes
contributes to lethality. To test the possibility that BChE has a vital
function in the nullizygote, a specific BChE inhibitor, bambuterol, was
injected i.p. at a dose of 0.3 mg/kg. The nullizygote immediately
showed signs of toxicity, was immobile by 6 min, and was dead by 10 min. Its normal littermates showed no signs of discomfort and survived.
This result showed that in the absence of AChE, essential activities
are provided by BChE or other serine esterases.
|
| |
Discussion |
|---|
|
|
|---|
The finding that a mouse is able to live for up to 3 weeks postnatally despite being devoid of AChE activity in all tissues was totally unanticipated. This novel result is expected to influence viewpoints on the functional importance of AChE.
Development. The normal maturation and development of heterozygous animals demonstrated that the reduction in AChE activity to 50% of normal was sufficient to support development and growth. Although a complete absence of AChE did not impede embryonic organogenesis, it did restrict continued development after birth. Several possible explanations exist for this interesting combination of findings, including that the nullizygous animals are nutritionally deficient or are unable to obtain sufficient calories to sustain growth. The continuous tremulous motion of nullizygous animals may require a caloric intake beyond that of wild-type animals. Alternatively, AChE may contribute a structural or functional activity that is necessary to complete synaptogenesis and normal maturation. If the hydrolytic activity of AChE is necessary for embryogenesis and life-sustaining functions such as respiration, this function may be compensated by BChE or other serine esterases in the nullizygous animals.
The timing of nullizygote death corresponded to several important developmental milestones. The second week after birth is an active period of rodent brain development, including the growth of axons and dendrites, establishment of neural connections, synapse elimination, and beginning of myelination (Davison and Dobbing, 1968Neuromuscular Junction.
Less than 5% of AChE found in the
body is anchored to the basal lamina of the neuromuscular junction
through a collagen tail (Hall and Sanes, 1993
; Feng et al., 1999
).
Humans with mutations in the collagen tail gene have end-plate AChE
deficiency (Donger et al., 1998
; Ohno et al., 1998
). Their junctional
folds degenerate, causing the loss of acetylcholine receptor. Mice
lacking the gene for the collagen tail have no AChE or BChE in the
neuromuscular junction, and their junctional folds also degenerate
(Feng et al., 1999
). The apparently intact neuromuscular junctions in
AChE
/
mice suggest that the structural integrity of the
neuromuscular junction might be maintained by the collagen tail alone
or by collagen-tailed BChE.
Organophosphate Sensitivity.
The finding that AChE
/
mice are supersensitive to the toxic effects of organophosphate shows
that organophosphate inhibition of targets other than AChE leads to
death. This result may not come as a surprise to toxicologists who have
noticed that different organophosphorus pesticides cause different
degrees of toxicity despite similar levels of AChE inhibition and have
postulated the existence of toxicologically relevant sites of action in
addition to AChE (Moser, 1995
; Pope, 1999
; Richards et al., 1999
). What might these other targets be? The present work suggests that BChE might
be a target in AChE
/
mice, but others are also likely. Members of
the serine esterase family, including carboxylesterase, proline
endopeptidase, leucine aminopeptidase, lipases, phospholipase, vitellogenin, Zn-dependent exopeptidase, cholesterol esterase, phosphatidylcholine-sterol acyltransferase, prolylcarboxypeptidase, and
carboxypeptidase, are possibilities because they contain an active site
serine (http://meleze.ensam.inra.fr/cholinesterase/). A serine esterase
with no homology to the above proteins, neuropathy target esterase
(Lush et al., 1998
), is inhibited by certain organophosphates. Organophosphorus pesticides exert effects on proteins that have no
active site serine: nicotinic receptor, muscarinic receptors, voltage-dependent chloride channel,
-aminobutyric
acidA receptor, catecholaminergic pathways, and
pathways that release neurotransmitters (Gant et al., 1987
; Dam et al.,
1999
; Pope, 1999
). The AChE
/
mouse should be useful for
identifying toxicologically relevant targets.
mouse with its lower level of AChE activity
and greater sensitivity to the toxic effects of organophosphorus toxicants provides a model for supersensitivity to these agents. The
finding that mice deficient in one AChE allele are healthy and capable
of reproduction raises the question of whether heterozygous AChE
deficiency in humans (Johns, 1962| |
Acknowledgments |
|---|
We thank Bin Li for assaying mouse tissues, Phyllis Blease for sectioning mouse brains, Douglas C. Rennie and Rick Vaughn for electron microscopy, Steven Potter (Children's Hospital, University of Cincinnati, Cincinnati, OH) for the gift of plasmid MJK-KO, and Andrew Smolen (Institute of Behavioral Genetics, University of Colorado, Boulder, CO) and Virginia Moser (Environmental Protection Agency, Research Triangle Park, NC) for advice on toxicity studies.
| |
Footnotes |
|---|
Accepted for publication January 28, 2000.
Received for publication November 29, 1999.
1 This work was supported by U.S. Army Medical Research and Materiel Command DAMD 17-94-J-4005 and DAMD 17-97-1-7349 (to O.L.), Association Francaise Contre les Myopathies (MNM1997) (A.C.), Nebraska State Research Initiative (S.H.H., A.R.), University of Nebraska Medical Center Seed Grant 98-005 (O.L.), and U.S. Public Health Service Grants GM18360 (P.T.) and R01-DA011707 (O.L.). Core facilities of the University of Nebraska Medical Center Cancer Center used in this work were supported in part by a Center Grant from the National Cancer Institute (Laboratory Cancer Research Center Support Grant CA36727). The opinions or assertions contained herein belong to the authors and should not be construed as the official views of the U.S. Army or the Department of Defense.
Send reprint requests to: Dr. Oksana Lockridge, University of Nebraska Medical Center, Eppley Institute, 986805 Nebraska Medical Center, Omaha, NE 68198-6805. E-mail: olockrid{at}unmc.edu
| |
Abbreviations |
|---|
AChE, acetylcholinesterase enzyme; ACHE, acetylcholinesterase gene; BChE, butyrylcholinesterase enzyme; DFP, diisopropylfluorophosphate; iso-OMPA, tetraisopropylpyrophosphoramide.
| |
References |
|---|
|
|
|---|
gene expression followed by late-onset neuromotor deterioration.
Proc Natl Acad Sci USA
94:
8173-8178This article has been cited by other articles:
![]() |
M.-X. Silveyra, G. Evin, M.-F. Montenegro, C. J. Vidal, S. Martinez, J. G. Culvenor, and J. Saez-Valero Presenilin 1 Interacts with Acetylcholinesterase and Alters Its Enzymatic Activity and Glycosylation Mol. Cell. Biol., May 1, 2008; 28(9): 2908 - 2919. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Camp, A. De Jaco, L. Zhang, M. Marquez, B. De La Torre, and P. Taylor Acetylcholinesterase Expression in Muscle Is Specifically Controlled by a Promoter-Selective Enhancesome in the First Intron J. Neurosci., March 5, 2008; 28(10): 2459 - 2470. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Li, E. G. Duysen, M. Carlson, and O. Lockridge The Butyrylcholinesterase Knockout Mouse as a Model for Human Butyrylcholinesterase Deficiency J. Pharmacol. Exp. Ther., March 1, 2008; 324(3): 1146 - 1154. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Martinez-Pena y Valenzuela and M. Akaaboune Acetylcholinesterase Mobility and Stability at the Neuromuscular Junction of Living Mice Mol. Biol. Cell, August 1, 2007; 18(8): 2904 - 2911. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Mis Colocalization of acetylcholinesterase, butyrylcholinesterase and choline acetyltransferase in rat spinal cord Human and Experimental Toxicology, October 1, 2005; 24(10): 543 - 545. [Abstract] [PDF] |
||||
![]() |
E. S. Peeples, L. M. Schopfer, E. G. Duysen, R. Spaulding, T. Voelker, C. M. Thompson, and O. Lockridge Albumin, a New Biomarker of Organophosphorus Toxicant Exposure, Identified by Mass Spectrometry Toxicol. Sci., February 1, 2005; 83(2): 303 - 312. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Mis, T. Mars, M. Jevsek, M. Brank, K. Zajc-Kreft, and Z. Grubic Localization of mRNAs Encoding Acetylcholinesterase and Butyrylcholinesterase in the Rat Spinal Cord by Nonradioactive In Situ Hybridization J. Histochem. Cytochem., December 1, 2003; 51(12): 1633 - 1644. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. A. Volpicelli-Daley, A. Hrabovska, E. G. Duysen, S. M. Ferguson, R. D. Blakely, O. Lockridge, and A. I. Levey Altered Striatal Function and Muscarinic Cholinergic Receptors in Acetylcholinesterase Knockout Mice Mol. Pharmacol., December 1, 2003; 64(6): 1309 - 1316. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Darreh-Shori, O. Almkvist, Z. Z. Guan, A. Garlind, B. Strandberg, A.-L. Svensson, H. Soreq, E. Hellstrom-Lindahl, and A. Nordberg Sustained cholinesterase inhibition in AD patients receiving rivastigmine for 12 months Neurology, August 27, 2002; 59(4): 563 - 572. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. J. A. Janssen and J. F. M. Smits Autonomic control of blood pressure in mice: basic physiology and effects of genetic modification Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2002; 282(6): R1545 - R1564. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. G. Duysen, B. Li, W. Xie, L. M. Schopfer, R. S. Anderson, C. A. Broomfield, and O. Lockridge Evidence for Nonacetylcholinesterase Targets of Organophosphorus Nerve Agent: Supersensitivity of Acetylcholinesterase Knockout Mouse to VX Lethality J. Pharmacol. Exp. Ther., November 1, 2001; 299(2): 528 - 535. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Bertrand, A. Chatonnet, C. Takke, Y. Yan, J. Postlethwait, J.-P. Toutant, and X. Cousin Zebrafish Acetylcholinesterase Is Encoded by a Single Gene Localized on Linkage Group 7. GENE STRUCTURE AND POLYMORPHISM; MOLECULAR FORMS AND EXPRESSION PATTERN DURING DEVELOPMENT J. Biol. Chem., January 5, 2001; 276(1): 464 - 474. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||